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N-myc is a transcription factor expressed in the developing metanephric kidney and other organs. In mice, complete
disruption of the N-myc gene results in fetal death on the first day of renal organogenesis. In addition to the null N-myc
allele, others have generated a hypomorphic N-myc allele. In this study, combinations of these mutant genes were used to
demonstrate that reduction in N-myc protein levels correlate with fewer developing glomeruli and collecting ducts in
embryonic kidney explants. Histological sections revealed that the mutant kidneys were hypoplastic with normal
developing structures. The data indicate that the hypoplasia is due to a reduction in proliferation rather than an increase in
apoptosis. Thus, N-myc loss causes a decrease in numbers of ureteric bud tips and developing glomeruli in explants and
hypoplastic kidneys in vivo, in a dose-dependent manner. © 2000 Academic Press






















Bilateral renal hypoplasia is a leading cause of chronic
renal failure in childhood, accounting for approximately
20% of all cases (Bernstein, 1992). At present, molecular
mechanisms responsible for hypoplasia are unknown.
Other congenital kidney abnormalities such as dysplasia or
aplasia are reproduced in the mouse with targeted disrup-
tion of genes such as glial cell line-derived neurotrophic
factor (Sanchez et al., 1996) or c-ret (Schuchardt et al.,
1994). Mutations of other genes expressed in mouse embry-
onic kidneys do not display renal phenotypes (Davies and
Bard, 1998). Disruption of N-myc leads to early embryonic
lethality with uncertain effects on the kidney (Lipschutz,
1998).
Myc proteins are developmentally expressed basic helix-
loop-helix leucine zipper transcription factors (reviewed in
Henriksson and Lu¨scher, 1996; Grandori and Eisenman,
1997). c-myc was first identified as the chicken cellular
homolog of oncogene v-myc (Henriksson and Lu¨scher,
1996). N-myc was later isolated from human neuroblasto-
mas as an amplified gene having significant sequence ho-
mology with c-myc (Kohl et al., 1983). Before binding to
promoters, myc proteins form heterodimers with other
factors and then either activate or repress transcription t
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enes have been identified, the proteins appear to regulate
ell growth, apoptosis, and transformation (Henriksson and
u¨scher, 1996).
N-myc and c-myc differ in their expression patterns. Both
ppear in mouse embryonic tissues, but only c-myc is
ormally detected in the adult (Stanton and Parada, 1992).
-myc and c-myc are often coexpressed, but often with
ifferent levels of abundance. Mouse embryonic livers dis-
lay high levels c-myc transcript, but little N-myc, while
ervous tissues express abundant N-myc mRNA, but little
r no c-myc (Stanton et al., 1992). In other developing
rgans such as the lung and intestine, c-myc mRNA is
estricted to mesenchymal cells and N-myc mRNA to
pithelial cells (Stanton et al., 1992). In the embryonic
idney, c-myc is detected in uninduced metanephric mes-
nchyme and N-myc in early induced mesenchymal con-
ensates, while both are excluded from the ureteric bud
pithelium (Patterson and Dressler, 1994).
Metanephric kidneys develop from two tissue precursors,
he ureteric bud and the metanephric mesenchyme (re-
iewed in Davies and Bard, 1998). At gestational day 11.5
E11.5) in the mouse, the ureteric bud appears as an evagi-
ation of the nephric duct in the region of the hindlimb and




























318 Bates et al.chymal tissue adjacent to the ureteric bud (Davies and Bard,
1998). The two tissues then come into contact and begin a
series of reciprocal inductive signals leading to the forma-
tion of the kidney (Davies and Bard, 1998). The mesen-
chyme stimulates the ureteric bud to begin branching
successively (Davies and Bard, 1998). At each terminal tip,
the ureteric bud induces local areas of mesenchyme to
condense; these condensates eventually convert into the
epithelium of the nephrons (Davies and Bard, 1998). The
ureteric bud terminal tips then fuse with the nephrons and
form the collecting ducts and ureters (Davies and Bard,
1998).
Researchers in the 1950s noted that explanted mouse
ureteric bud and metanephric mesenchyme tissues will
undergo apoptosis if grown separately (Grobstein, 1953).
However, if dissected en bloc from the embryo after making
contact, ureteric bud and mesenchymal tissues can grow
and develop into a structure resembling a kidney (Grob-
stein, 1953). The ureteric bud will branch multiple times
and the mesenchyme will be induced to form early epithe-
lial nephron rudiments (Grobstein, 1953). These explants
express histological markers, such as N-myc, in patterns
consistent with embryonic kidneys in vivo (Saxen, 1987;
ugrauer and Ekblom, 1991).
Despite the high level of N-myc expression in the meta-
ephric blastema, targeted disruption of N-myc leads to
etal demise at E11.5 in the mouse, so that the effects on the
idney could not be determined (Charron et al., 1992;
tanton et al., 1992). A hypomorphic N-myc mutation (H)
as also been generated (Moens et al., 1992). Mice homozy-
ous for the hypomorphic mutation (HH) express approxi-
ately 25% of the N-myc protein levels found in wild-type
ittermates and die shortly after birth of lung hypoplasia
Moens et al., 1992). When the null mutation is combined
ith the hypomorphic allele (NH), embryos die of apparent
eart defects between E12.5 and E14.5 (Moens et al., 1993).
HH embryos were reported as having normal kidneys up
until birth (Moens et al., 1992); however, four NH embryos
were described as having small kidneys prior to death at
E14.5 (Moens et al., 1993).
The purpose of our study was to examine the effects of
-myc mutations on the developing kidney. To circumvent
roblems with early embryonic death from the NN and NH
utations, we used embryonic kidney explants to charac-
erize effects on the ureteric bud and metanephric mesen-
hyme. When possible, we also compared sizes and histol-
gy of N-myc mutant and control kidneys in vivo at later
tages of development.
METHODS
Animals. Two- to three-month-old mice heterozygous for null
(NW) and/or hypomorphic (HW) N-myc alleles were mated to
generate embryos with NN, NH, or HH genotypes. The H allele
was in an ICR mouse strain background. The N-myc null allele was
in a combined C57BL/6 and 129Sv (approximately 50% each)
Copyright © 2000 by Academic Press. All rightmouse strain background, but was then backcrossed into the ICR
strain three times. Subsequent NH embryos were approximately
93.75% ICR.
Explant studies. At E11.5, embryonic kidneys were dissected
and cultured for 3 days in Dulbecco’s modified Eagle medium
(GIBCO) with 10% fetal bovine serum (GIBCO). Yolk sacs were
saved for genotyping. Explants were then fixed in cold methanol
(whole-mount studies) or frozen in OCT (Sakura Finetek, Inc.)
embedding medium (cryosection studies).
To genotype the explants, yolk sacs were digested overnight at
55°C with a solution containing 100 mM Tris–HCl, pH 8.5, 5 mM
EDTA, 0.2% SDS, 200 mM NaCl, and 100 mg/ml proteinase K
Sigma). DNA was precipitated and resuspended in 200 ml TE (25
mM Tris, pH 8.5, 1 mM EDTA). Samples were genotyped by
polymerase chain reaction as previously reported (Moens et al.,
1993).
Whole-mount immunofluorescence was performed with mouse
antibodies against pancytokeratins (Sigma) to label the ureteric bud
or WT-1 (Santa Cruz) to label developing glomeruli (Cho et al.,
1998). Briefly, methanol-fixed explants were blocked in phosphate-
buffered saline (PBS) with 2% milk and 0.5% Triton X for 1 h.
Explants were labeled with mouse anti-pancytokeratins (1:8)
and/or rabbit anti-WT-1 (1:100) in blocking solution. After being
washed with blocking solution, the explants were incubated for 1 h
in goat anti-mouse antibodies (for pancytokeratin) conjugated with
Cy3 (1:500) (Jackson) or Cy2 (1:10) (Jackson) and/or goat anti-rabbit
antibodies (for WT-1) conjugated with Cy3 (1:500) (Jackson). Rep-
resentative samples were photographed with either a 35-mm or a
digital camera (Optronics) mounted on a microscope (Leica or
Olympus). The ureteric bud terminal tips and WT-1-labeled glo-
meruli were then counted with the operator blinded to the geno-
types. Mean mutant bud tip and glomerular numbers were then
compared with those of littermates by unpaired t tests (P , 0.05
was considered significant). Each experiment was repeated three
times.
Explants were also cryosectioned at 7 mm and fixed in 4%
araformaldehyde in PBS. Samples were then dual labeled for 1 h
ith anti-pancytokeratins (1:8) to stain ureteric bud epithelium
nd anti-WT-1 (1:100), rabbit anti-laminin (1:100) (Sigma), or rabbit
nti-pax2 (5 mg/ml) (Babco) to detect developing epithelial struc-
ures in the mesenchyme (Torres et al., 1995; Cho et al., 1998).
After being washed in PBS, the slides were incubated for 30 min in
a mixture of goat anti-mouse Cy3-conjugated antibodies (1:500)
and goat anti-rabbit FITC- (1:25) or Cy2- (1:10) conjugated antibod-
ies. Representative samples were photographed as above. Each
experiment was repeated three times.
In vivo studies. E13.5 and E18.5 HH and viable E13.5 NH
embryos or kidneys were obtained (along with yolk sacs for
genotyping) and placed into Bouins solution (70% picric acid, 10%
formalin, 5% acetic acid) overnight. Samples were washed daily
with 70% ethanol for 4–6 days. Some of the E13.5 embryos were
transverse-sectioned (5 mm—paraffin) and stained with hematoxy-
in and eosin (H&E) (as in Bates et al., 1997). Some of the E18.5 HH
nd WW kidneys were longitudinally sectioned (5 mm) and H&E
stained.
At E13.5, relative kidney lengths of NH and WW littermates
(N 5 6 each) and HH and WW littermates (N 5 8 each) were
compared from photographs. A ratio of NH or HH kidney length to
WW littermate length was obtained. The means of the ratios of the
NH–WW and the HH–WW lengths were calculated and compared
(with WW–WW normalized to 1) by a one-way analysis of variance
(ANOVA). E18.5, mean HH and WW kidney lengths (N 5 6 each)
s of reproduction in any form reserved.
F319N-myc in Developing KidneyFIG. 1. Double-label immunofluorescence of wild-type (WW) kidney and N-myc null (NN) explant sections after 3 days in culture. (a and
b) Pax-2 (green) and pancytokeratin (orange) antibody staining in wild-type (a) and null (b) explants. (c and d) WT-1 (green) and
pancytokeratin (orange) antibody staining in wild-type (c) and null (d) explants. (e and f) Laminin (green) and pancytokeratin staining in
wild-type (e) and null (f ) explants (arrows, developing nephron epithelia derived from metanephric mesenchyme arrowheads, ureteric buds)
(2003 original magnifications).
IG. 2. Representative whole-mount WT-1 (red) and pancytokeratin (green) immunofluorescence of N-myc mutant and wild-type kidney
explants cultured for 3 days. (a) N-myc null explants. (b) N-myc null-hypomorph heterozygous explants. (c) Wild-type explants (1003
original magnifications).














































320 Bates et al.were compared by unpaired t tests (P , 0.05 was considered
significant for t tests and ANOVA).
Mean whole embryo crown–rump lengths in E13.5 NH (N 5 8)
and WW (N 5 15), E13.5 HH (N 5 8) and WW (N 5 7), and E18.5
H and WW (N 5 5 each) were compared by unpaired t tests (P ,
.05 was considered significant).
Cell proliferation/apoptosis assays. To measure apoptosis,
12.5 and E13.5 NH and WW embryo transverse sections (5
mm—paraffin) were assayed by terminal uridine triphosphate (UTP)
end-labeling (TUNEL) (as in Farinas et al., 1996). Briefly, sections
were treated with proteinase K at 10 mg/ml for 10 and then 3%
2O2 for 5 min. After treatment with terminal transferase (TdT)
uffer (Gibco) for 15 min, sections were incubated with 40 mM
biotinylated UTP (Gibco) and 0.3 units/ml TdT (Gibco) for 1 h at
7°C (one slide without TdT added as negative control). Tissues
ere then washed with 23 SSC and then blocked with 2% horse
erum in PBS. After washing, sections were incubated with an
vidin:biotinylated horseradish peroxidase complex (ABC) (Vector
aboratories, Inc.) for 30 min at room temperature. The complex
as visualized with DAB and the tissue lightly counterstained
ith hematoxylin. The experiments were performed three times.
To measure cell proliferation, bromodeoxyuridine (BrdU) assays
ere performed (as in Mokry and Nemecek, 1995) on E12.5 and
13.5 embryos whose mothers were intraperitoneally injected with
mg of BrdU 1 or 4 h prior to sacrifice. Transverse paraffin sections
5 mm) were incubated in 3% H2O2 for 30 min followed by pepsin
t 200 mg/ml for 20 min. Samples were then bathed in 2 N HCl for
40 min followed by 0.1 M sodium borate, pH 8.5, for 10 min.
Sections were blocked in 2% horse serum for 1 h and then
incubated with mouse anti-BrdU antibodies (1:20) (Becton–
Dickinson, Inc.) overnight at 4°C (one slide incubated without
antibody as a negative control). After washes in PBS, samples were
treated with goat anti-mouse antibody conjugated with biotin
(1:400) (Vector Laboratories, Inc.) for 1 h. ABC solution was applied,
followed by DAB and light hematoxylin staining.
To quantitate cell proliferation at E12.5, NH and WW litter-
mates (N 5 6 each) were serially cut and every fourth to fifth
section (20–25 mm) was stained for BrdU as above (five sections
total). Numbers of BrdU-positive (brown) and -negative (blue) cells
were counted for both metanephric mesenchyme and epithelial
ureteric bud. On average, a total of 4084 mesenchymal cells and
440 ureteric bud cells were counted for each WW embryo, while
3445 mesenchymal cells and 380 ureteric bud cells were counted
for each NH embryo. Proliferation for each tissue type was calcu-
lated from the ratio of BrdU-positive to total nuclei (brown plus
blue) in NH and WW. Mean percentages of proliferation were then




Since N-myc is expressed in metanephric mesenchymal
condensates, we hypothesized that interruption of the gene
would inhibit the mesenchymal to epithelial conversion.
N-myc null embryos die before this process occurs in vivo;
therefore, we utilized embryonic kidney explants to test the
hypothesis. Unfortunately, 60–70% of the null embryos
harvested at E11.5 (first day of metanephric kidney forma-
tion) were undergoing reabsorption and we were unable to
Copyright © 2000 by Academic Press. All rightissect out kidney anlage. The null explants we did obtain
ere smaller than their wild-type counterparts and did not
ncrease in size significantly over the 3 days in culture, in
ontrast to the controls. After 3 days in culture, we fixed,
ryosectioned, and immunostained the tissues with anti-
odies against pax-2, laminin, or WT-1 to identify develop-
ng nephron epithelia and pancytokeratins to visualize the
reteric bud (Fig. 1). Despite their smaller size, the null
utant explants labeled for pax-2, laminin, and WT-1,
uggesting that the mesenchymal to epithelial conversion
an occur in the absence of N-myc.
Since the viable N-myc null explants did not grow as well
s their wild-type counterparts, we tested whether N-myc
eletion affected ureteric bud branching morphogenesis and
umbers of developing glomeruli. After 3 days in culture,
e fixed explants and performed whole-mount immuno-
uorescence with antibodies against pancytokeratins
nd/or WT-1. N-myc null kidneys did demonstrate signifi-
ant reductions in numbers of ureteric bud branches and
eveloping glomeruli (Fig. 2a) relative to wild-type controls
Fig. 2c).
Since many of the 11.5-day null explants were smaller
nd possibly undergoing reabsorption at the time of dissec-
ion, we were concerned that the effects on ureteric bud
ranching and glomerular number were nonspecific. To
ircumvent this problem, we performed similar studies on
xplants dissected from embryos carrying one null (N) and
ne hypomorphic (H) allele. These compound heterozy-
otes possess approximately 15% N-myc protein levels
elative to wild-type embryos (Moens et al., 1993) and while
sometimes smaller, they are otherwise indistinguishable
from wild-type embryos at 11.5 days gestation (Moens et
al., 1993). Thus, at the time of dissection, we were unable to
identify which of the embryos and explants were NH
mutants. After 3 days in culture, we again performed
whole-mount immunolabeling with antibodies against pan-
cytokeratins and/or WT-1. The null-hypomorph (NH) mu-
tant explants demonstrated many more ureteric bud
branches and glomeruli than NN mutants, but fewer
branches than their wild-type counterparts (Fig. 2). Al-
though the NH and NN explants demonstrate progressively
fewer ureteric bud branches than the wild-type, the overall
pattern of branching appears intact (Fig. 2). Explants from
other heterozygous embryos with one wild-type allele (NW
and HW) were indistinguishable from wild type (not
shown).
To quantitate the effects of the N-myc null-hypomorph
mutation on the explants, we counted numbers of develop-
ing glomeruli and ureteric bud tips after WT-1 and pancy-
tokeratin staining, respectively. The numbers of glomeruli
and terminal tips did not vary among the wild type, the NW
heterozygotes, or the HW heterozygotes (not shown) and
therefore the controls included all three groups. The null-
hypomorph mutants demonstrated a 20.3% reduction in
mean numbers of developing glomeruli relative to controls
[21.2 6 0.7 versus 26.6 6 0.5, respectively (P , 0.0001)]
(Fig. 3b). Similarly, NH explants displayed 24.2% decrease





















































321N-myc in Developing Kidneyin mean ureteric bud tips relative to controls [32.0 6 1.2
versus 42.3 6 0.7, respectively (P , 0.0001)] (Fig. 3a).
Interestingly, when the embryos were products of parents
from different mouse strains (ICR crossed with a combined
129 Sv/C57BL6 strain) the reduction in NH mean ureteric
bud tips increased to 39.9% relative to controls [21.8 6 1.3
ersus 36.3 6 1.3, respectively (P , 0.0001)].
We also quantified the ureteric bud tip numbers in
hypomorph-homozygous (HH) embryos. HH mutants were
reported to be the same size as and indistinguishable from
other littermates at E11.5 and to develop up until birth,
when they die of respiratory failure (Moens et al., 1992).
Densitometry studies on Northern blots demonstrated that
HH embryonic kidneys have 35% N-myc mRNA transcript
levels relative to controls (Moens et al., 1992). We dissected
HH mutant embryonic kidneys at E11.5 and were unable to
distinguish them from other littermates. After 3 days in
culture, however, we found that the HH explants demon-
strated a 18.4% reduction in ureteric bud tip numbers
relative to controls [26.9 6 1.1 versus 32.9 6 0.8, respec-
tively (P , 0.0001)].
In Vivo Comparisons
Since the in vitro data suggested that N-myc expression
levels correlated with ureteric bud branch and glomerular
number, we tested whether reductions in N-myc affected
kidney development in vivo. Although murine kidney de-
velopment starts at E11.5, significant ureteric bud branch-
ing and early nephron formation does not begin until E13.5.
Although NN embryos die at E11.5, most NH embryos are
viable at E12.5 and a small number reach E14.5 (Moens et
al., 1993). We generated multiple litters from NW and HW
matings and found that only 5–10% of the E13.5 NH
FIG. 3. Graphs comparing numbers of ureteric bud tips (a) and
developing glomeruli (b) in N-myc null-hypomorphic (NH) and
control (CON) explants after 3 days in culture. Mean numbers of
CON and NH ureteric bud tips (control N 5 128, mutant N 5 44)
and glomeruli (control N 5 167, mutant N 5 60) were signifi-
cantly different (each with P , 0.0001). Squares represent the
means, the ends of the vertical lines are outliers, and the three
horizontal lines are the 25th, 50th, and 75th percentiles, respec-
tively.mutants were viable. Similar to previous reports (Moens et (
Copyright © 2000 by Academic Press. All rightl., 1993), the viable NH mutants had cervical body wall
dema in comparison to littermates. The mutants did
ppear slightly smaller than their littermates, but crown–
ump lengths were not significantly different [9.50 6 0.27
m versus 9.98 6 0.21 mm, respectively (P 5 0.19)]. The
H embryos did not appear to be developmentally retarded.
We dissected whole kidneys and performed H&E stains
n transverse sections of viable E13.5 NH mutants and
heir littermates. E13.5 null-hypomorph kidneys were sig-
ificantly smaller than controls, with an average decrease
n renal length of 24.5% (P , 0.0001) (Figs. 4a and 4b).
ross sections of the E13.5 embryos in the region of the
idneys confirmed that the volume of the renal paren-
hyma is reduced, but that normal developing structures
re present (Figs. 4c–4f). Both mutant and control kidneys
emonstrate developing S-shaped and comma bodies in the
uxtamedullary cortex, while noncondensing mesenchyme
redominates in the outer cortex. Branching ureteric bud
tructures also appear in both mutants and controls (Figs.
c–4f).
We performed similar experiments on hypomorph-
omozygous (HH) embryos, first at E13.5 and then again at
18.5. Previous reports indicated that from E12.5 until
18.5, the HH embryos were slightly smaller than litter-
ates, but not developmentally retarded (Moens et al.,
993). At E13.5, HH mutants were indistinguishable from
iable E13.5 NH mutants, i.e., the E13.5 hypomorph ho-
ozygotes were slightly smaller than littermates, but
rown–rump lengths were not significantly different
9.38 6 0.16 mm versus 9.86 6 0.21 mm, respectively (P 5
.084)] (not shown). HH mutant kidneys were smaller
elative to littermate kidneys, although the average renal
ength was reduced by only 17.4% (P , 0.0001) (not
hown). Furthermore, the decrease in kidney length relative
o littermates was significantly greater in the null-
ypomorph versus hypomorph homozygotes [27.5 6 2.7%
ersus 17.4 6 2.0%, respectively (P , 0.05)]. As with NH
utants, transverse sections of E13.5 HH embryos demon-
trated a reduction in renal parenchymal volume, but
ormal developing structures (not shown).
At E18.5, HH mutants were still developmentally com-
arable to littermates, although the difference in embryo
ize was slightly larger than at E13.5 (Figs. 5a and 5b). E18.5
ild-type embryo crown–rump lengths measured on aver-
ge 6.7% longer than HH crown–rump lengths [2.23 6
.034 cm versus 2.08 6 0.015 cm, respectively (P , 0.05)].
lthough the embryo length discrepancy was approxi-
ately 2% greater at E18.5 than at E13.5, the difference in
idney sizes was even more dramatic (Figs. 5c and 5d).
18.5 hypomorph-homozygous kidney lengths were on av-
rage 26.5% smaller than wild-type littermates (as opposed
o 17.4% at E13.5) [2.00 6 0.049 mm versus 2.72 6 0.062
m, respectively (P , 0.0001). Longitudinal sections of
18.5 HH kidneys revealed a normal architecture, but
onfirmed the vast reduction in size relative to littermates
Figs. 5e and 5f).












322 Bates et al.Proliferation and Apoptosis Studies
Since N-myc mutant kidneys appeared hypoplastic rela-
tive to controls, we tested whether N-myc reduction was
associated with an increase in apoptosis and/or a decrease
in proliferation in E12.5 and E13.5 NH embryos. For the
apoptosis studies, we used the TUNEL assay. To test for
proliferation, we determined percentage BrdU incorpora-
tion into embryos after injecting pregnant females with
BrdU by intraperitoneal route 1 h prior to sacrifice.
The pattern of apoptosis in null-hypomorph and wild-
type kidneys was similar, at both E12.5 (Figs. 6a and 6b) and
E13.5 (not shown). The staining was sporadic and in the
FIG. 4. Comparison of E13.5 N-myc null-hypomorph (NH) and wi
wild-type (a) and null-hypomorph (b) embryos (1003 original magn
and e) and null-hypomorph (d and f) embryos in region of kidneys
bodies) (c and d, 403 original magnifications; e and f, 1003 origin
FIG. 5. Comparison of E18.5 N-myc hypomorph homozygous (HH
hypomorph-homozygous (b) embryos (73 original magnifications)
hypomorph-homozygous (d) embryos (403 original magnifications)
hypomorph-homozygous (f) kidneys (403 original magnifications).medullary and juxtamedullary regions of the kidneys (Figs. s
Copyright © 2000 by Academic Press. All righta and 6b) and did not appear in negative controls (not
hown). In contrast, NH kidneys at both E12.5 and E13.5
emonstrated marked reductions in BrdU uptake through-
ut the developing cortex compared with wild-type litter-
ates (Figs. 6c–6f). Similar data were obtained at E12.5
hen BrdU was injected 4 h prior to sacrifice (not shown).
To quantitate the reduction in proliferation, we deter-
ined the percentage of BrdU-positive versus total cells in
12.5 NH mutant and wild-type littermates injected 1 h
rior to harvest. We also tested whether the decreases in
rdU uptake were in the ureteric bud cells or in metaneph-
ic mesenchymal cells. Although embryonic kidneys are
e (WW) kidneys. (a and b) Whole unstained kidneys dissected from
tions). (c–f) H&E stains of transverse sections through wild-type (c
ws, kidneys; convex arrows, comma bodies; arrowheads, S-shaped
gnifications)
d wild-type (WW) embryos and kidneys. (a and b) Wild-type (a) and
nd d) Whole unstained kidneys dissected from wild-type (c) and






. (e aignificantly larger at E12.5 than at E11.5, the metanephric




323N-myc in Developing Kidneymesenchyme has not yet started forming epithelial struc-
tures of future nephrons (Davies and Bard, 1998); therefore,
the epithelial ureteric bud cells are easy to distinguish from
mesenchymal cells. Since only nuclei were stained, how-
ever, we were unable to distinguish between condensing
and noncondensing metanephric mesenchymal tissues. We
detected sharp reductions in both total metanephric mes-
enchymal and ureteric bud proliferation in E12.5 null-
hypomorph mutants relative to controls (Fig. 7). Null-
hypomorph kidney mesenchymal cells demonstrated a
25.3% decrease in BrdU staining in comparison to litter-
mates [39.3 6 1.29% versus 52.6 6 0.75%, respectively (P ,
FIG. 6. Comparison of apoptosis and proliferation in N-myc null-
region of kidneys. (a and b) TUNEL assays in E12.5 wild-type (a) and
(c–f) BrdU incorporation in E12.5 and E13.5 wild-type (c and e, resp
(c and d, 1003 original magnifications; e and f, 403 original magn.0001)], while ureteric bud cell proliferation decreased by
Copyright © 2000 by Academic Press. All right1.8% [46.5 6 2.86% versus 59.5 6 1.59%, respectively
P , 0.0001)].
DISCUSSION
Our data provide strong evidence that N-myc has a
pivotal role in kidney development. Although previous
reports on N-myc mutations were unable to address the
effects on the metanephric kidney due to early embryonic
lethality (Stanton et al., 1992a; Charron et al., 1992), we
used organ explants in part to circumvent this problem.
morph (NH) and wild-type (WW) embryonic transverse sections in
-hypomorph (b) embryonic kidneys (1003 original magnifications).
ely) and null-hypomorph (d and f, respectively) embryonic kidneys
ions).hypo
null
ectivAlthough complete disruption of N-myc does not prevent











324 Bates et al.the mesenchymal to epithelial conversion into early
nephrons, the numbers of developing nephrons and ureteric
bud tips were reduced dramatically. Using combinations of
hypomorphic and null alleles, we demonstrated that pro-
gressive decreases in N-myc levels demonstrated more
severe phenotypes, despite no apparent differences in ex-
plants at the time of dissection. In vivo, reduction in N-myc
levels was associated with kidney hypoplasia disproportion-
ate to the effects on the whole embryo. As with the
explants, the expression level of N-myc correlated with the
severity of the in vivo kidney phenotypes (although at
E13.5, NH and HH embryos were of a similar size). Taken
together, the explant and in vivo data support a direct role
of N-myc in kidney development.
Explant Data
The mechanisms of the N-myc effects on the explants are
unknown. The reduction in ureteric bud branching could be
direct although a secondary mechanism is more likely
given that N-myc expression has not been described in bud
epithelium. The effect on glomerular number would more
likely be direct given that N-myc is expressed in nephron
precursor tissue. Alternatively, fewer glomeruli may be the
result of the decrease in ureteric bud tip number. Regard-
less, these data are consistent with what has been reported
in the mesonephric kidney, which develops earlier but in a
manner analogous to the metanephric kidney. The original
articles on N-myc deletion noted that mutant embryos had
normal-appearing mesonephric nephrons, but a reduction
in number (Stanton et al., 1992a; Charron et al., 1992).
The severity of the N-myc mutation in explants varies
with the mouse strain. In a 50% ICR, 25% C57BL/6, and
25% 129Sv background, the null-hypomorph explants had
an average of 39.9% fewer ureteric bud tips than controls
after 3 days in culture. When the ICR background was
FIG. 7. Comparison of proliferation in metanephric mesenchyme
and ureteric bud tissues of E12.5 null-hypomorph (NH) and wild-
type (WW) embryonic kidneys. Significant differences were de-
tected in both the metanephric mesenchymal cells (P , 0.0001)
nd the ureteric bud cells (P , 0.005).increased to 93.75%, the decrease in NH ureteric bud
Copyright © 2000 by Academic Press. All rightranching was only 24.2%. This phenomenon has been
eported for a variety of other targeted mutations (Ewart-
oland et al., 1999; LeCouter et al., 1998; Zhu et al., 1998).
or example, smad 3 null mutant mice develop colon
denocarcinoma 100% of the time in a pure 129Sv strain,
ut less than 30% of the time in a hybrid 129Sv/C57Bl/6
ackground (Zhu et al., 1998). Thus, modifier genes in the
29Sv and/or C57BL/6 strain likely increase the severity of
he N-myc mutations.
In Vivo Data
The effect of N-myc reduction on whole embryonic
kidneys correlated well with the organ culture data. At
E13.5, both the NH and the HH mutants had significant
decreases in kidney size relative to littermates. Further, the
kidney defect is hypoplasia (normal developing renal tissues
with a reduction in mass), as opposed to dysplasia (abnor-
mally forming kidney structures), as is often seen in other
mutations such as with GDNF (Sanchez et al., 1996) or c-ret
(Schuchardt et al., 1994). Hypoplasia would be the predicted
in vivo phenotype given that N-myc mutant explants
display normal-developing mesenchymal and ureteric bud
structures, albeit with a reduction in numbers of those
structures.
Proliferation/Apoptosis Data
The hypoplasia seen in N-myc mutant kidneys appears to
be due to a decrease in cell proliferation and not to an
increase in apoptosis. NH and wild-type E12.5 and E13.5
kidneys displayed similar patterns of apoptosis with spo-
radic labeling in the medullary and juxtamedullary regions
(Fig. 6). The staining pattern is very similar to that of
previously published reports examining apoptosis in devel-
oping kidney using TUNEL assays (Dudley and Robertson,
1997). Labeling in other developing organs, such as the
dorsal root ganglion (not shown), was also similar to other
published reports (Farin˜as et al., 1996). In contrast to the
TUNEL staining, the differences in BrdU incorporation in
NH mutant and control E12.5 and E13.5 kidneys are very
apparent (Fig. 6). Furthermore, both the ureteric bud and the
metanephric mesenchymal tissues in the E12.5 N-myc
mutant kidneys demonstrated statistically significant de-
creases in proliferation (Fig. 7).
How N-myc mutations cause decreases in kidney tissue
proliferation is unclear. One possibility is that a reduction
in N-myc protein levels leads to downregulation of the cell
cycle. Key mediators of the cell cycle such as ornithine
decarboxylase and CDC25A contain putative myc binding
elements in their promoters (Roussel, 1998). Other cell
cycle components such as cyclins E and A, and CDC25B,
are also thought to be regulated by members of the myc
family (Roussel, 1998). N-myc may also directly or indi-
rectly regulate growth factors important to kidney develop-
ment, such as GDNF or its ligand c-ret. In either case, the
effects of N-myc on kidney tissue proliferation are appar-




325N-myc in Developing Kidneyently both autocrine and paracrine since both the ureteric
bud and the metanephric mesenchyme are affected. How
N-myc loss has non-cell-autonomous effects on ureteric
bud development remains to be determined.
In summary, we have demonstrated that reductions in
N-myc protein levels are associated with fewer ureteric bud
branches and developing glomeruli in mouse embryonic
kidney explants. In vivo, N-myc mutant embryos demon-
trate hypoplastic kidneys. The effects of N-myc on the in
itro explants and the in vivo kidneys appear to be dose-
dependant. Finally, the hypoplastic kidneys are the result of
a decrease in cell proliferation and not to an increase in
apoptosis.
ACKNOWLEDGMENTS
We thank Dr. Greg Dressler for teaching us organ culture
techniques. We thank Dr. Raymond Quigley, Dr. Dan Liebl, Dr.
Marty Turman, and Yuan Zhu for helpful discussions. We thank
Kim Meyers for all of her assistance. This study was supported by
grants from the National Institutes of Health, 5-K08-DK02571-02,
and the Texas National Kidney Foundation (C.B.) and Excellence in
Education Foundation support for Developmental Biology (L.F.P).
REFERENCES
Bates, C. M., Merenmies, J. M., Kelly-Spratt, K. S., and Parada, L. F.
(1997). Insulin receptor-related receptor is expressed in non-A
intercalated cells in the kidney. Kidney Int. 51, 674–681.
ernstein, J. (1992). Renal hypoplasia and dysplasia. In “Pediatric
Kidney Disease” (C. Edelman Jr., Ed.), Vol. II, pp. 1121–1137.
Little, Brown, Boston.
Bouchard, C., Staller, P., and Eilers, M. (1998). Control of cell
proliferation by myc. Trends Cell. Biol. 8, 202–207.
Charron, J., Malynn, B. A., Fisher, P., Stewart, V., Jeannotte, L.,
Goff, S. P., Robertson, E. J., and Alt, F. W. (1992). Embryonic
lethality in mice homozygous for a targeted disruption of the
N-myc gene. Genes Dev. 6, 2248–2257.
Cho, E. A., Patterson, L. T., Brookhiser, W. T., Mah, S., Kintner, C.,
and Dressler, G. R. (1998). Differential expression and function of
cadherin-6 during renal epithelium development. Development
125, 803–812.
Davies, J. A., and Bard, J. B. (1998). The development of the kidney.
Curr. Top. Dev. Biol. 39, 245–301.
Dudley, A. T., and Robertson, E. J. (1997). Overlapping expression
domains of bone morphogenetic protein family members poten-
tially account for limited tissue defects in BMP7 deficient
embryos. Dev. Dyn. 208, 349–362.
Ewart-Toland, A., Mounzih, K., Qiu, J., and Chehab, F. F. (1999).
Effect of the genetic background on the reproduction of leptin-
deficient obese mice. Endocrinology 140, 732–738.
Farinas, I., Yoshida, C. K., Backus, C., and Reichardt, L. F. (1996).
Lack of neurotrophin-3 results in death of spinal sensory neurons
and premature differentiation of their precursors. Neuron 17,
1065–1078.
Grandori, C., and Eisenman, R. N. (1997). Myc target genes. Trends
Biochem. Sci. 22, 177–181.
Grobstein, C. (1953). Inductive epithelio-mesenchymal interaction
in cultured organ rudiments of the mouse. Science 11, 52–55.
Copyright © 2000 by Academic Press. All rightHenriksson, M., and Luscher, B. (1996). Proteins of the Myc
network: Essential regulators of cell growth and differentiation.
Adv. Cancer Res. 68, 109–182.
Kohl, N. E., Kanda, N., Schreck, R. R., Bruns, G., Latt, S. A.,
Gilbert, F., and Alt, F. W. (1983). Transposition and amplification
of oncogene-related sequences in human neuroblastomas. Cell
35, 359–367.
LeCouter, J. E., Kablar, B., Whyte, P. F., Ying, C., and Rudnicki,
M. A. (1998). Strain-dependent embryonic lethality in mice
lacking the retinoblastoma-related p130 gene. Development 125,
4669–4679.
Lipschutz, J. H. (1998). Molecular development of the kidney: A
review of the results of gene disruption studies. Am. J. Kidney
Dis. 31, 383–397.
Moens, C. B., Auerbach, A. B., Conlon, R. A., Joyner, A. L., and
Rossant, J. (1992). A targeted mutation reveals a role for N-myc
in branching morphogenesis in the embryonic mouse lung.
Genes Dev. 6, 691–704.
Moens, C. B., Stanton, B. R., Parada, L. F., and Rossant, J. (1993).
Defects in heart and lung development in compound heterozy-
gotes for two different targeted mutations at the N-myc locus.
Development 119, 485–499.
Mokry, J., and Nemecek, S. (1995). Immunohistochemical detec-
tion of cells labeled with bromo-deoxyuridine after neural trans-
plantation. Mol. Chem. Neurop. 25, 235–245.
Mugrauer, G., and Ekblom, P. (1991). Contrasting expression pat-
terns of three members of the myc family of protooncogenes in
the developing and adult mouse kidney. J. Cell. Biol. 112, 13–25.
Patterson, L. T., and Dressler, G. R. (1994). The regulation of
kidney development: New insights from an old model. Curr.
Opin. Genet. Dev. 4, 696–702.
Roussel, M. (1998). Key effectors of signal transduction and G1
progression. Adv. Cancer Res. 74, 1–24.
Sanchez, M. P., Silos-Santiago, I., Frisen, J., He, B., Lira, S. A., and
Barbacid, M. (1996). Renal agenesis and the absence of enteric
neurons in mice lacking GDNF. Nature 382, 70–73.
Saxen, L. (1987). Organogenesis of the kidney. In “Developmental
and Cell Biology Series” (P. W. Barlow, P. B. Green, and C. C
White, Eds.),Vol. 19. Cambridge Univ. Press, Cambridge, UK.
Schuchardt, A., D’Agati, V., Larsson-Blomberg, L., Costantini, F.,
and Pachnis, V. (1994). Defects in the kidney and enteric nervous
system of mice lacking the tyrosine kinase receptor Ret. Nature
367, 380–383.
Stanton, B. R., and Parada, L. F. (1992). The N-myc proto-oncogene:
Developmental expression and in vivo site-directed mutagenesis.
Brain Pathol. 2, 71–83.
Stanton, B. R., Perkins, A. S., Tessarollo, L., Sassoon, D. A., and
Parada, L. F. (1992). Loss of N-myc function results in embryonic
lethality and failure of the epithelial component of the embryo to
develop. Genes Dev. 6, 2235–2247.
Torres, M., Gomez-Pardo, E., Dressler, G. R., and Gruss, P. (1995).
Pax-2 controls multiple steps of urogenital development. Devel-
opment 121, 4057–4065.
Zhu, Y., Richardson, J. A., Parada, L. F., and Graff, J. M. (1998).
Smad3 mutant mice develop metastatic colorectal cancer. Cell
94, 703–714.
Received for publication August 26, 1999
Revised March 21, 2000Accepted March 21, 2000
s of reproduction in any form reserved.
